scholarly journals Diagnostic accuracy of the Patient Health Questionnaire-9 for assessment of depression in type II diabetes mellitus and/or coronary heart disease in primary care

2016 ◽  
Vol 190 ◽  
pp. 68-74 ◽  
Author(s):  
G. Lennart van der Zwaan ◽  
Susan E.M. van Dijk ◽  
Marcel C. Adriaanse ◽  
Harm W.J. van Marwijk ◽  
Maurits W. van Tulder ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Primary Care ◽  
Coronary Heart Disease ◽  
Heart Disease ◽  
Diagnostic Accuracy ◽  
Type Ii Diabetes ◽  
Type Ii Diabetes Mellitus ◽  
Type Ii ◽  
Health Questionnaire ◽  
Patient Health

Adherence to clinical guidelines in the prevention of coronary heart disease in type II diabetes mellitus

2007 ◽  
Vol 30 (1) ◽  
pp. 120-127 ◽  
Author(s):  
Majidreza Kamyar ◽  
B. Julienne Johnson ◽  
John J. McAnaw ◽  
Rosa Lemmens-Gruber ◽  
Steve A. Hudson
Keyword(s):  
Diabetes Mellitus ◽  
Coronary Heart Disease ◽  
Heart Disease ◽  
Clinical Guidelines ◽  
Type Ii Diabetes ◽  
Type Ii Diabetes Mellitus ◽  
Type Ii

scholarly journals Coronary Heart Disease in Postmenopausal Women with Type II Diabetes Mellitus and the Impact of Estrogen Replacement Therapy: A Narrative Review

2014 ◽  
Vol 2014 ◽  
pp. 1-8 ◽  
Author(s):  
Marouane Boukhris ◽  
Salvatore Davide Tomasello ◽  
Francesco Marzà ◽  
Sonia Bregante ◽  
Francesca Romana Pluchinotta ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Coronary Heart Disease ◽  
Heart Disease ◽  
Cardiovascular Risk ◽  
Type Ii Diabetes ◽  
Estrogen Replacement Therapy ◽  
Type Ii Diabetes Mellitus ◽  
Type Ii ◽  
Estrogen Replacement ◽  
The Impact

Coronary heart disease is the main cause of death in postmenopausal women (PMW); moreover its mortality exceeds those for breast cancer in women at all ages. Type II diabetes mellitus is a major cardiovascular risk factor and there is some evidence that the risk conferred by diabetes is greater in women than in men. It was established that the deficiency of endogenous estrogens promotes the atherosclerosis process. However, the impact of estrogen replacement therapy (ERT) on cardiovascular prevention remains controversial. Some authors strongly recommend it, whereas others revealed a concerning trend toward harm. This review tries to underlines the different components of cardiovascular risk in diabetic PMW and to define the place of ERT.

scholarly journals Features of vasoregulatory function of vascular endothelium and correlations between them, hemodynamic and metabolic parameters in patients with coronary heart disease and type 2 diabetes mellitus

2021 ◽  
pp. 28-30
Author(s):  
О. О. Pogrebniak
Keyword(s):  
Diabetes Mellitus ◽  
Coronary Heart Disease ◽  
Heart Disease ◽  
Vascular Endothelium ◽  
Type Ii Diabetes ◽  
Glycosylated Hemoglobin ◽  
Type Ii Diabetes Mellitus ◽  
Type Ii ◽  
Very Low Density Lipoproteins ◽  
Fasting Glycemia

The features of the vasoregulating function of the vascular endothelium have been determined and correlations between haemodynamic and metabolic indices have been established in patients with coronary heart disease associated with type II diabetes mellitus. In patients with coronary heart disease associated with type II diabetes mellitus in comparison with patients without an association with diabetes mellitus significantly higher indices of the content of the blood fibrinogen the diameter of the brachial artery (after decompression) were observed. Direct correlations between fasting glycemia and microalbuminuria and reverse correlations with the endothelial dependent vasodilatation (EDVA), fasting glucemia, the blood content of glycosylated hemoglobin and very low density lipoproteins have been found.

scholarly journals Risk factors for coronary heart disease in type II diabetes mellitus

2005 ◽  
Vol 20 (2) ◽  
pp. 75-80 ◽  
Author(s):  
H. Surekha Rani ◽  
G. Madhavi ◽  
V. Ramachandra Rao ◽  
B. K. Sahay ◽  
A. Jyothy
Keyword(s):  
Diabetes Mellitus ◽  
Risk Factors ◽  
Coronary Heart Disease ◽  
Heart Disease ◽  
Type Ii Diabetes ◽  
Type Ii Diabetes Mellitus ◽  
Type Ii

scholarly journals Obesity. An imbalance of energy or an imbalance of nutrients?

1997 ◽  
Vol 43 (5) ◽  
pp. 47-50
Author(s):  
M. M. Ginzburg ◽  
G. S. Kozupitsa
Keyword(s):  
Diabetes Mellitus ◽  
Coronary Heart Disease ◽  
Type Ii Diabetes ◽  
Developed Countries ◽  
Type Ii Diabetes Mellitus ◽  
Common Disease ◽  
Type Ii ◽  
Current State ◽  
Prevention Therapy ◽  
And Control

Obesity is now the most common disease in the population of economically developed countries, where up to 25% of residents have a body weight that is more than 15% higher than normal [8]. An increase in the incidence rate of about 10% over 10 years is observed [33]. The causal relationship between obesity and arterial hypertension, coronary heart disease, and type II diabetes mellitus is well known [6, 10]. At the same time, the current state of the problem of prevention, therapy and control of relapse of obesity is far from perfect. And this is primarily due to the fact that we do not fully know the pathogenesis of this disease.

scholarly journals Сhanges in the quality of life of patients undergoing coronary stenting and with concomitant pathology

2021 ◽  
Vol 22 (3) ◽  
pp. 32-37
Author(s):  
A. A. Abdullaev ◽  
R. M. Gafurova ◽  
U. A. Islamova ◽  
R. G. Khabchabov ◽  
E. R. Makhmudova ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Diabetes Mellitus ◽  
Myocardial Infarction ◽  
Heart Disease ◽  
Angina Pectoris ◽  
Arterial Hypertension ◽  
Type Ii Diabetes ◽  
Type Ii Diabetes Mellitus ◽  
Type Ii

Goal — was to assess the quality of life of patients with coronary heart disease, concomitant type II diabetes mellitus and arterial hypertension at 2 years after coronary stenting. Material and methods. The study included 103 patients aged 44 to 67 years. Clinical and laboratory results were assessed after stenting of the coronary arteries, 2 years later in an outpatient setting. The patients were divided into two groups: the 1st group included 54 patients with ischemic heart disease, angina pectoris III–IV f.c. in combination with arterial hypertension; in the 2nd group — 49 patients with ischemic heart disease, angina pectoris III–IV f.k. in combination with arterial hypertension and type II diabetes mellitus. The study was carried out in accordance with Good Clinical Practice and Declaration of Helsinki principles. The study protocol was approved by the Ethics Committees of all participating clinical centers. Written informed consent was obtained from all participants prior to enrollment.Results. In our study, 103 patients with ischemic heart disease and angina pectoris III–IV f.c. Within 2 years after coronary artery stenting, 33 cases of myocardial infarction (32.0%) were registered. The quality of life improved to stable exertional angina pectoris I–II f.k. 34 patients (33.0%). At the same time, 39.8% did not change their quality of life. Myocardial infarction in the group with angina pectoris III–IV f.k. and arterial hypertension, developed in 12 (22.2%) patients, and in the group with angina pectoris III–IV f.c. and arterial hypertension + type II diabetes mellitus were registered in 21 (42.8%) patients, which is almost twice as high as in group 1, the same for improving the quality of life. That is, despite the stenting of the coronary arteries, the high incidence of complications in the form of myocardial infarction can be explained by a combination of concomitant diseases, in the form of arterial hypertension + type II diabetes mellitus. We are confident that type II diabetes mellitus has a greater impact on the quality of life and complications in patients who have undergone coronary stenting. At the same time, the risk of complications decreases with adequate control of arterial hypertension and type II diabetes mellitus — the transition of angina pectoris III–IV to I–II f.c. characterized by a significant improvement at p-0.0034; odds ratio 0.50; the confidence interval is 0.31–0.80. Conclusion. The improvement in the quality of life in patients with coronary heart disease and arterial hypertension after stenting of the coronary arteries in the long-term period is twice as good as in patients with coronary heart disease and arterial hypertension + type II diabetes mellitus. Arterial hypertension is a serious but manageable risk factor for the development of macrovascular and microvascular complications. The study demonstrated the effectiveness of correcting only arterial hypertension in terms of preventing cardiovascular and microvascular complications than the combination of arterial hypertension and type II diabetes mellitus, which significantly worsen the prognosis of the disease in patients with coronary artery disease after coronary artery stenting. This is reflected in the recommendations for stratification of the risk of arterial hypertension and type II diabetes mellitus.

Sign in / Sign up

Export Citation Format

Share Document